TEMPUS LABS INC for TEMPUS LABS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Medicare/Medicaid MMM
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Science/Technology SCI
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Medical/Disease Research/Clinical Labs MED
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.